14-day RSI
57.03
+0.86+1.53%
29 November 2024
Summary:
CRISPR Therapeutics AG stock 14-day relative strength index is 57.03, with the most recent change of +0.86 (+1.53%) on 29 November 2024. According to this value, CRSP stock is neither oversold nor overboughtCRSP RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +1.5% | -0.4% | +0.1% | -0.3% |
| 1 m1 month | +2.8% | +4.3% | +1.9% | -3.1% |
| 3 m3 months | +37.5% | +5.6% | -9.6% | -8.9% |
| 6 m6 months | +37.1% | -4.3% | -19.3% | -4.9% |
| ytdytd | +14.9% | -19.1% | -17.3% | +5.0% |
| 1 y1 year | -14.9% | -26.6% | -2.9% | +8.5% |
| 5 y5 years | -22.1% | -29.1% | +1.3% | +29.8% |
CRSP RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 68.89 | -17.2% | 42.45 | +34.4% |
| 3 m | 3 months | 68.89 | -17.2% | 35.02 | +62.9% |
| 6 m | 6 months | 68.89 | -17.2% | 32.00 | +78.2% |
| 1 y | 1 year | 73.62 | -22.5% | 24.27 | +135.0% |
| 3 y | 3 years | 79.01 | -27.8% | 24.27 | +135.0% |
| 5 y | 5 years | 86.39 | -34.0% | 21.54 | +164.8% |
| alltime | all time | 95.99 | -40.6% | 0.00 | -100.0% |
CRISPR Therapeutics AG Stock RSI History
| Date | Value |
|---|---|
| 2024 | 57.03(+14.9%) |
| 2023 | 49.64(+64.2%) |
| 2022 | 30.24(-30.4%) |
| 2021 | 43.42(-21.9%) |
| Date | Value |
|---|---|
| 2020 | 55.58(+32.1%) |
| 2019 | 42.07(-0.5%) |
| 2018 | 42.29(-43.4%) |
| 2017 | 74.71(+42.6%) |
| 2016 | 52.38 |
FAQ
- What is CRISPR Therapeutics AG 14-day relative strength index?
- What is the all time high 14-day RSI for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG 14-day relative strength index?
The current 14-day RSI of CRSP is 57.03
What is the all time high 14-day RSI for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high 14-day relative strength index is 95.99